These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29655371)

  • 1. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.
    Stampanoni Bassi M; Iezzi E; Marfia GA; Simonelli I; Musella A; Mandolesi G; Fresegna D; Pasqualetti P; Furlan R; Finardi A; Mataluni G; Landi D; Gilio L; Centonze D; Buttari F
    J Neuroinflammation; 2018 Apr; 15(1):108. PubMed ID: 29655371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis.
    Mori F; Nicoletti CG; Rossi S; Motta C; Kusayanagi H; Bergami A; Studer V; Buttari F; Barbieri F; Weiss S; Nisticò R; Martino G; Furlan R; Centonze D
    Neuromolecular Med; 2014 Jun; 16(2):490-8. PubMed ID: 24671722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis.
    Mango D; Nisticò R; Furlan R; Finardi A; Centonze D; Mori F
    Neurochem Res; 2019 Mar; 44(3):726-733. PubMed ID: 29392518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis.
    Mori F; Rossi S; Piccinin S; Motta C; Mango D; Kusayanagi H; Bergami A; Studer V; Nicoletti CG; Buttari F; Barbieri F; Mercuri NB; Martino G; Furlan R; Nisticò R; Centonze D
    J Neurosci; 2013 Dec; 33(49):19112-9. PubMed ID: 24305808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study.
    Harirchian MH; Tekieh AH; Modabbernia A; Aghamollaii V; Tafakhori A; Ghaffarpour M; Sahraian MA; Naji M; Yazdankhah M
    Eur J Neurol; 2012 Feb; 19(2):241-7. PubMed ID: 21771201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.
    Stampanoni Bassi M; Iezzi E; Mori F; Simonelli I; Gilio L; Buttari F; Sica F; De Paolis N; Mandolesi G; Musella A; De Vito F; Dolcetti E; Bruno A; Furlan R; Finardi A; Marfia GA; Centonze D; Rizzo FR
    Neurorehabil Neural Repair; 2019 Oct; 33(10):825-835. PubMed ID: 31431121
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
    Trentini A; Castellazzi M; Romani A; Squerzanti M; Baldi E; Caniatti ML; Pugliatti M; Granieri E; Fainardi E; Bellini T; Cervellati C
    J Neurol Sci; 2017 Jun; 377():133-136. PubMed ID: 28477683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
    Albanese M; Zagaglia S; Landi D; Boffa L; Nicoletti CG; Marciani MG; Mandolesi G; Marfia GA; Buttari F; Mori F; Centonze D
    J Neuroinflammation; 2016 Feb; 13():36. PubMed ID: 26863878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
    Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
    J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging.
    Cid C; Alcázar A; Regidor I; Masjuan J; Salinas M; Alvarez-Cermeño JC
    J Neurol Sci; 2002 Jan; 193(2):103-9. PubMed ID: 11790390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
    Stampanoni Bassi M; Iezzi E; Landi D; Monteleone F; Gilio L; Simonelli I; Musella A; Mandolesi G; De Vito F; Furlan R; Finardi A; Marfia GA; Centonze D; Buttari F
    J Neurol; 2018 Nov; 265(11):2540-2547. PubMed ID: 30167879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
    Anagnostouli M; Katsavos S; Kyrozis A; Gontika M; Voumvourakis KI; Kapaki E
    Neurol Res; 2016 Aug; 38(8):655-62. PubMed ID: 27625006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach.
    Stampanoni Bassi M; Gilio L; Buttari F; Maffei P; Marfia GA; Restivo DA; Centonze D; Iezzi E
    Front Neurosci; 2017; 11():710. PubMed ID: 29321723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiology of synaptic functioning in multiple sclerosis.
    Stampanoni Bassi M; Mori F; Buttari F; Marfia GA; Sancesario A; Centonze D; Iezzi E
    Clin Neurophysiol; 2017 Jul; 128(7):1148-1157. PubMed ID: 28511127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
    Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
    Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
    Magliozzi R; Howell OW; Nicholas R; Cruciani C; Castellaro M; Romualdi C; Rossi S; Pitteri M; Benedetti MD; Gajofatto A; Pizzini FB; Montemezzi S; Rasia S; Capra R; Bertoldo A; Facchiano F; Monaco S; Reynolds R; Calabrese M
    Ann Neurol; 2018 Apr; 83(4):739-755. PubMed ID: 29518260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
    Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.